John Spoors
YOU?
Author Swipe
View article: Exploring patient and clinician perspectives on the benefits and risks of emerging therapies for the treatment of haemophilia: a qualitative study
Exploring patient and clinician perspectives on the benefits and risks of emerging therapies for the treatment of haemophilia: a qualitative study Open
Background Enhanced horizon scanning for emerging treatments has identified that both haemophilia A and haemophilia B pathways will be enriched with a range of new medicines with varying benefit-risk profiles. Patient and clinician views o…
View article: An evaluation of managed access agreements in England based on stakeholder experience
An evaluation of managed access agreements in England based on stakeholder experience Open
Objectives The objective of this research was to evaluate managed access policy in England, drawing upon the expertise of a range of stakeholders involved in its implementation. Methods Seven focus groups were conducted with payer and heal…
View article: Early access schemes for innovative health technologies: the views of international stakeholders
Early access schemes for innovative health technologies: the views of international stakeholders Open
Objectives Early access schemes (EASs) are approaches used by payers to balance and facilitate earlier patient access to innovative health technologies while evidence generation is ongoing. Schemes require investment from payers and are as…
View article: Discrete choice experiments: An overview of experience to date in haemophilia
Discrete choice experiments: An overview of experience to date in haemophilia Open
Background The patient voice is an important consideration in the availability and choice of pharmaceuticals – however, how to capture this complex area and apply it formally within regulation, health technology assessment and reimbursemen…